✦ LIBER ✦

A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal caner

✍ Scribed by Malcolm J. Moore; Leonard Kaizer; Charles Erlichman; Robert Myers; Ron Feld; Jake J. Thiessen; Sheldon Fine

Publisher: Springer
Year: 1995
Tongue: English
Weight: 492 KB
Volume: 37
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685633

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Fluorouracil/leucovorin/interferon alp

5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer

✍ Peter B. Vermeulen; Luc Y. Dirix; Gino Pelgrims; Allan T. van Oosterom; Nanno H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 2 views

Alpha-interferon in combination with 5-f

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study

✍ C. J. A. Punt; P. H. M. Mulder; J. Th. M. Burghouts; D. J. Th. Wagener 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 331 KB

Phase II study of oral eniluracil, 5-flu

Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma

✍ Neal J. Meropol; Donna Niedzwiecki; Donna Hollis; Richard L. Schilsky; Robert J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 3 views

Treatment of patients with advanced colo

Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil, and leucovorin

✍ Werner Scheithauer; H. Rosen; R. Schiessel; J. Schüller; M. Karall; F. Ernst; Ch 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

5-fluorouracil/leucovorin/interferon alp

5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration

✍ Jan Buter; Harm A. M. Sinnige; Dirk Th. Sleijfer; Elisabeth G. E. de Vries; Pax 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Bimonthly high dose leucovorin and 5-flu

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma

✍ Christophe Tournigand; Christophe Louvet; Aimery de Gramont; Elisabeth Lucchi; J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

disease progression. IFN was administered subcutaneously three times weekly at for the Groupe d'Etude et de a dose of 3 MU (body surface area [BSA] õ 1.75 m 2 ) or 4.5 MU (BSA ¢ 1.75 m 2 ). Recherche sur les Cancers de RESULTS. World Health Organization toxicity Grade 3-4 occurred in 21 patients l'O